Cargando…
Optical injection of mammalian cells using a microfluidic platform
The use of a focused laser beam to create a sub-micron hole in the plasma membrane of a cell (photoporation), for the selective introduction of membrane impermeable substances (optical injection) including nucleic acids (optical transfection), is a powerful technique most commonly applied to treat s...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Optical Society of America
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017997/ https://www.ncbi.nlm.nih.gov/pubmed/21258487 http://dx.doi.org/10.1364/BOE.1.000527 |
_version_ | 1782196002756755456 |
---|---|
author | Marchington, Robert F. Arita, Yoshihiko Tsampoula, Xanthi Gunn-Moore, Frank J. Dholakia, Kishan |
author_facet | Marchington, Robert F. Arita, Yoshihiko Tsampoula, Xanthi Gunn-Moore, Frank J. Dholakia, Kishan |
author_sort | Marchington, Robert F. |
collection | PubMed |
description | The use of a focused laser beam to create a sub-micron hole in the plasma membrane of a cell (photoporation), for the selective introduction of membrane impermeable substances (optical injection) including nucleic acids (optical transfection), is a powerful technique most commonly applied to treat single cells. However, particularly for femtosecond photoporation, these studies have been limited to low throughput, small-scale studies, because they require sequential dosing of individual cells. Herein, we describe a microfluidic photoporation system for increased throughput and automated optical injection of cells. Hydrodynamic focusing is employed to direct a flow of single-file cells through a focused femtosecond laser beam for photoporation. Upon traversing the beam, a number of transient pores potentially open across the extracellular membrane, which allows the uptake of the surrounding fluid media into the cytoplasm, also containing the chosen injection agent. The process is entirely automated and a rate of 1 cell/sec could readily be obtained, enabling several thousand cells to be injected per hour using this system. The efficiency of optically injecting propidium iodide into HEK293 mammalian cells was found to be 42 ± 8%, or 28 ± 4% taking into account the requirement of post-injection viability, as tested using Calcein AM. This work now opens the way for combining photoporation with microfluidic analyses, sorting, purification or on-chip cell culture studies. |
format | Text |
id | pubmed-3017997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Optical Society of America |
record_format | MEDLINE/PubMed |
spelling | pubmed-30179972011-01-21 Optical injection of mammalian cells using a microfluidic platform Marchington, Robert F. Arita, Yoshihiko Tsampoula, Xanthi Gunn-Moore, Frank J. Dholakia, Kishan Biomed Opt Express Microfluidics The use of a focused laser beam to create a sub-micron hole in the plasma membrane of a cell (photoporation), for the selective introduction of membrane impermeable substances (optical injection) including nucleic acids (optical transfection), is a powerful technique most commonly applied to treat single cells. However, particularly for femtosecond photoporation, these studies have been limited to low throughput, small-scale studies, because they require sequential dosing of individual cells. Herein, we describe a microfluidic photoporation system for increased throughput and automated optical injection of cells. Hydrodynamic focusing is employed to direct a flow of single-file cells through a focused femtosecond laser beam for photoporation. Upon traversing the beam, a number of transient pores potentially open across the extracellular membrane, which allows the uptake of the surrounding fluid media into the cytoplasm, also containing the chosen injection agent. The process is entirely automated and a rate of 1 cell/sec could readily be obtained, enabling several thousand cells to be injected per hour using this system. The efficiency of optically injecting propidium iodide into HEK293 mammalian cells was found to be 42 ± 8%, or 28 ± 4% taking into account the requirement of post-injection viability, as tested using Calcein AM. This work now opens the way for combining photoporation with microfluidic analyses, sorting, purification or on-chip cell culture studies. Optical Society of America 2010-08-09 /pmc/articles/PMC3017997/ /pubmed/21258487 http://dx.doi.org/10.1364/BOE.1.000527 Text en ©2010 Optical Society of America http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work is properly cited. This license restricts the article from being modified or used commercially. |
spellingShingle | Microfluidics Marchington, Robert F. Arita, Yoshihiko Tsampoula, Xanthi Gunn-Moore, Frank J. Dholakia, Kishan Optical injection of mammalian cells using a microfluidic platform |
title | Optical injection of mammalian cells using a microfluidic platform |
title_full | Optical injection of mammalian cells using a microfluidic platform |
title_fullStr | Optical injection of mammalian cells using a microfluidic platform |
title_full_unstemmed | Optical injection of mammalian cells using a microfluidic platform |
title_short | Optical injection of mammalian cells using a microfluidic platform |
title_sort | optical injection of mammalian cells using a microfluidic platform |
topic | Microfluidics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017997/ https://www.ncbi.nlm.nih.gov/pubmed/21258487 http://dx.doi.org/10.1364/BOE.1.000527 |
work_keys_str_mv | AT marchingtonrobertf opticalinjectionofmammaliancellsusingamicrofluidicplatform AT aritayoshihiko opticalinjectionofmammaliancellsusingamicrofluidicplatform AT tsampoulaxanthi opticalinjectionofmammaliancellsusingamicrofluidicplatform AT gunnmoorefrankj opticalinjectionofmammaliancellsusingamicrofluidicplatform AT dholakiakishan opticalinjectionofmammaliancellsusingamicrofluidicplatform |